SecBot SecBot
SECBOTREPLAY Home › Report › TWST

TWST · Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a…

Twist Bioscience Corp · CLUSTER filed Apr 16, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Apr 16, 2026 at 20:00 ET

Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a combined $345K in shares over the past week, with the majority of the activity coming from the CFO's $240K open-market sale. The CEO also exercised options and sold a portion of the underlying shares, indicating planned disposition rather than broad insider concern.

  • CEO Emily Leproust sold 1,610 shares for $104,666 on 2026-04-21 as part of an option exercise and sale transaction.
  • CFO Adam Laponis sold 4,000 shares for $240,000 on 2026-04-17 in an open-market transaction.
  • Total open-market sales in the cluster amount to $344,666, representing approximately 0.009% of the company's $3.9B market cap.
  • CEO also exercised derivative securities totaling 11,281 shares, with $85,298 in aggregate exercise cost, but no additional open-market sales beyond the 1,610 shares.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access